Insulin Treatment Perception and Factors affecting the Acceptance in Type 2 Diabetes Mellitus Patients attending a Specialist Clinic in Ilorin, Nigeria
DOI:
https://doi.org/10.25026/jtpc.v8i2.650Keywords:
Insulin treatment, Type 2 diabetes mellitus, Perception, Acceptance, NigeriaAbstract
Type 2 Diabetes Mellitus (T2DM) is a significant global health challenge, with increasing prevalence and diverse management approaches. Insulin therapy, a cornerstone in the management of advanced T2DM, is often met with reluctance and negative perceptions. A better understanding of the multifaceted factors influencing insulin acceptance is crucial for tailored interventions. This study explored the perception regarding insulin treatment using the validated Insulin Treatment Appraisal Scale (ITAS). This study aimed to explore socio-demographic and clinical factors influencing insulin therapy perception and acceptance among T2DM patients in Ilorin, Nigeria. It was a cross-sectional study among T2DM patients. Data on socio-demographic characteristics, diabetes related features and ITAS were collected and analyzed. Statistical methods, including t-tests and chi square were employed to assess the impact of various variables on insulin treatment perception. There was a statistically significant difference (p=0.029) between the age of insulin naïve and experienced patients. Some insulin-experienced patients had positive perceptions of insulin, like their belief in insulin’s health benefits (p = 0.001) and ability to control blood glucose (p = 0.048). Insulin-naive individuals exhibited more negative attitudes toward insulin, emphasizing the need for targeted interventions and patients’ health education. This study provides valuable insights into the intricate interplay of socio-demographic characteristics, diabetes related features, and individual perceptions influencing insulin therapy acceptance among participants with T2DM. The findings underscore the importance of personalized interventions to address negative perceptions, ultimately enhancing diabetes management and treatment outcome.
Downloads
References
[1] Kaur R., Kaur M., Singh J. 2018. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovascular Diabetology, 17(1), 1-7.
[2] Behnam-Rassouli M., Ghayour MB., Ghayour N. 2010. Microvascular complications of diabetes. J Biol Sci, 10:411–23.
[3] Petznick AM. 2013. Identifying and addressing barriers to insulin acceptance and adherence in patients with type 2 diabetes mellitus. The Journal of the American Osteopathic Association, 113:6-16.
[4] Butler AE., Janson J., Bonner-Weir S., Ritzel R., Rizza RA., Butler PC. 2003. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 52(1), 102-110
[5] Sabei LT., Sammud M. 2015. Attitude towards insulin therapy among patients with type 2 diabetes in Tripoli, Libya. Ibnosina Journal of Medicine and Biomedical Sciences, 7(4), 127-35.
[6] Peyrot M., Rubin RR., Lauritzen T., Skovlund SE., Snoek FJ., Matthews DR. 2005. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care, 28(11), 2673-9.
[7] Prospective Diabetes Study 16. 1995. Overview of 6 years’ therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes, 44(11), 1249-1258.
[8] Rubino A., McQuay LJ., Gough SC., Kvasz M., Tennis P. 2007. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK. Diabet Med, 24:1412–1418.
[9] Nichols GA., Koo YH., Shah SN. 2007. Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy. J Gen Intern Med, 22:453–458.
[10] Kruger D., Spollett G. 2009. Addressing barriers to timely intensification of diabetes care: the relationship between clinical inertia and patient behaviour. Consultant, 49(7), 20–25.
[11] Peyrot M., Rubin RR., Khunti K. 2010. Addressing barriers to initiation of insulin in patients with type 2 diabetes. Prim Care Diabetes, 4(1), 11-18.
[12] Lee YK., Lee PY., Ng CJ. 2012. A qualitative study on healthcare professionals’ perceived barriers to insulin initiation in a multi-ethnic population. BMC Fam Pract, 13:28-35.
[13] Masood I., Saleem A., Hassan A., Zia A., Khan AT. 2016. Evaluation of diabetes awareness among general population of Bahawalpur, Pakistan. Primary Care Diabetes, 10(1), 3-9.
[14] Fisher AA., Laing JE., Stoeckel JE., Townsend JW. 1998. Handbook for Family Planning Operation Research Design. 2nd edn., New York. Population Council, pp: 43-45
[15] Ogbera AO., Kuku SF. 2012. Insulin use, prescription patterns, regimens and costs - a narrative from a developing country. Diabetol Metab Syndr, 4:50-55.
[16] Snoek FJ., Skovlund SE., Pouwer F. 2007. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health Qual Life Outcomes, 5:69-75
[17] Chen CC., Chang MP., Hsieh MH., Huang CY., Liao LN., Li TC. 2011. Evaluation of perception of insulin therapy among Chinese patients with type 2 diabetes mellitus. Diabetes Metab, 37:389–394.
[18] Saleem A., Masood I., Khan TM. 2016. Insulin perception among insulin-naïve type-2 diabetes mellitus patients in Pakistan. Cogent Medicine, 3(1), 12-29.
[19] Jasper US., Opara MC., Pyiki EB., Akinrolie O. 2014. Knowledge of insulin use and its determinants among Nigerian insulin requiring diabetes patients. Journal of Diabetes & Metabolic Disorders, 13(10), 2-8
[20] Priscilla S., Malarvizhi S., Das AK., Natarajan V. 2019. The level of knowledge and attitude on insulin therapy in patients with diabetes mellitus in a teaching hospital of Southern India. J Family Med Prim Care, 8:3287-91
[21] Olamoyegun MA., Akinlade AT., Ala OA. 2018. Audit of insulin prescription patterns and associated burden among diabetics in a tertiary health institution in Nigeria. Afri Health Sci, 18(4), 852-86
[22] Poe NED., Srichan P., Khunthason S., Apidechkul T., Suttana W. 2023. Prevalence and Factors Associated with Hyperglycemia among Myanmar Migrant Workers in Mueang District, Chiang Rai Province, Thailand: A Cross-Sectional Study. J Health Sci Med Res, 41(1), 1-14
[23] Boye KS., Jordan JB., Malik RE. 2021. Patient perceptions of and preferences between characteristics of injectable diabetes treatments. Diabetes Ther Res, 12:2387-2403.
[24] Yen FS., Wei JCC., Liu JS. 2020. The factors associated with insulin non persistence in persons with type 2 diabetes. Diabetes Res Clin Pract, 167:10-18.
[25] Tan WL., Asahar SF., Harun NL. 2015. Insulin therapy refusal among type II diabetes mellitus patients in Kubang Pasu district, Kedah, Malaysia. Singapore Medical Journal, 56:224-227.
[26] Nur Azmiah Z., Zulkarnain AK., Tahir A. 2011. Psychological insulin resistance among type 2 diabetes patients at public health clinics in Federal Territory of Malaysia. The International Medical Journal Malaysia, 10:7-12.
[27] Soylar P., Kadioglu BU., Kilic K. 2020. Investigation of the barriers about insulin therapy in patients with type 2 diabetes. Niger J Clin Pract, 23(1), 98-104
[28] Cosson E., Mauchant C., Benabbad I., Le Pape G., Le Bleis M., Bailleul F. 2019. Perceptions of insulin therapy in people with type 2 diabetes and physicians: A cross-sectional survey conducted in France. Patient Prefer Adherence, 13:251-260.
[29] Taylor Jr CG., Taylor G., Atherley A., Hambleton L., Unwin N., Adams P. 2017. The Barbados Insulin Matters (BIM) study: Barriers to insulin therapy among a population-based sample of people with type 2 diabetes in the Caribbean Island of Barbados. J Clin Transl Endocrinol, 8(8), 49-53.
[30] Hu J., Amirehsani KA., Wallace DC., Letwak S. 2012. The meaning of insulin to hispanic immigrants with type 2 diabetes and their families. Diabetes Educ, 38(2), 263-270.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of Tropical Pharmacy and Chemistry

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.